Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria.

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria.

Show other versions (1)

PURPOSE: Dihydroartemisinin-piperaquine (DP) is a fixed-dose artemisinin-based combination treatment. Field pharmacokinetic studies would be simplified and facilitated by being able to use small volume capillary assays rather than venous blood. The aim of this study was to describe the relationship...

Descrición completa

Detalles Bibliográficos
Main Authors:	Ashley, E, Stepniewska, K, Lindegardh, N, Annerberg, A, Tarning, J, Mcgready, R, Phaiphun, L, Singhasivanon, P, White, N, Nosten, F
Formato:	Journal article
Idioma:	English
Publicado:	2010

Títulos similares

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria
por: Ashley, E, et al.
Publicado: (2010)

Population pharmacokinetics of piperaquine after two different treatment regimens of dihydroartemisinin piperaquine in patients with acute uncomplicated falciparum malaria in Thailand
por: Tarning, J, et al.
Publicado: (2007)

Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
por: Rijken, M, et al.
Publicado: (2011)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria.
por: Adam, I, et al.
Publicado: (2012)

Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.
por: Tarning, J, et al.
Publicado: (2008)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria
por: Adam, I, et al.
Publicado: (2012)

Comparison of lumefantrine, mefloquine, and piperaquine concentrations between capillary plasma and venous plasma samples in pregnant women with uncomplicated falciparum and vivax malaria
por: Saito, M, et al.
Publicado: (2024)

Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria.
por: Tarning, J, et al.
Publicado: (2014)

Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.
por: Tarning, J, et al.
Publicado: (2009)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
por: Tarning, J, et al.
Publicado: (2012)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria
por: Tarning, J, et al.
Publicado: (2012)

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
por: Mcgready, R, et al.
Publicado: (2006)

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
por: McGready, R, et al.
Publicado: (2009)

Electrocardiographic safety evaluation of dihydroartemisinin piperaquine in the treatment of uncomplicated falciparum malaria.
por: Mytton, O, et al.
Publicado: (2007)

Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
por: Tarning, J, et al.
Publicado: (2012)

Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria
por: Tarning, J, et al.
Publicado: (2012)

Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand.
por: Ashley, E, et al.
Publicado: (2004)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine
por: Zongo, I, et al.
Publicado: (2014)

A small amount of fat does not affect piperaquine exposure in patients with malaria.
por: Annerberg, A, et al.
Publicado: (2011)

A small amount of fat does not affect piperaquine exposure in patients with malaria.
por: Annerberg, A, et al.
Publicado: (2011)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.
por: Hoglund, R, et al.
Publicado: (2012)

Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria.
por: Ashley, E, et al.
Publicado: (2007)

Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria
por: Ashley, E, et al.
Publicado: (2007)

A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria.
por: Ashley, E, et al.
Publicado: (2005)

Population pharmacokinetic assessment of a new regimen of mefloquine used in combination treatment of uncomplicated falciparum malaria.
por: Ashley, E, et al.
Publicado: (2006)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine.
por: Issaka Zongo, et al.
Publicado: (2014-01-01)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated <it>Plasmodium falciparum</it> malaria in Sudan
por: Hoglund Richard M, et al.
Publicado: (2012-11-01)

Erratum:The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria(European Journal of Clinical Pharmacology (2006) 62 (1021-1031) DOI: 10.1007/s00228-006-0199-7)
por: Mcgready, R, et al.
Publicado: (2009)

Quantification of the antimalarial piperaquine in plasma.
por: Tarning, J, et al.
Publicado: (2008)

Pitfalls in estimating piperaquine elimination.
por: Tarning, J, et al.
Publicado: (2005)

Dihydroartemisinin - piperaquine rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report
por: Rijken, M, et al.
Publicado: (2007)

A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy.
por: Mcgready, R, et al.
Publicado: (2008)

Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria.
por: Mcgready, R, et al.
Publicado: (2006)

Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria.
por: Jamsen, K, et al.
Publicado: (2011)

Pharmacokinetic predictors for recurrent malaria after dihydroartemisinin-piperaquine treatment of uncomplicated malaria in Ugandan infants.
por: Creek, D, et al.
Publicado: (2013)

Dihydroartemisinin-piperaquine rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report.
por: Rijken, M, et al.
Publicado: (2008)

Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
por: Smithuis, F, et al.
Publicado: (2006)

In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003.
por: Ashley, E, et al.
Publicado: (2006)

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria
por: Lwin, K, et al.
Publicado: (2012)

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria.
por: Lwin, K, et al.
Publicado: (2012)